Darryl Maher
Fortune : 10 073 $ au 31/05/2026
Fortune : 10 073 $ au 31/05/2026
Darryl Maher currently works at Cynata Therapeutics Ltd., as Independent Non-Executive Director from 2020.
Dr. Maher also formerly worked at CSL Behring (Australia) Pty Ltd., as Vice President-Research & Development and Australian Pharmaceutical Physicians Association, as President.
Dr. Maher received his doctorate degree from the University of Melbourne.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2025 | 50 000 ( 0,02% ) | 10 073 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Directeur/Membre du Conseil | 16/06/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
Australian Pharmaceutical Physicians Association | President | - |
CSL Behring (Australia) Pty Ltd.
CSL Behring (Australia) Pty Ltd. BiotechnologyHealth Technology Engages in R&D and production of biotechnology products | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cynata Therapeutics Ltd.
Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
CSL Behring (Australia) Pty Ltd.
CSL Behring (Australia) Pty Ltd. BiotechnologyHealth Technology Engages in R&D and production of biotechnology products | Health Technology |
Australian Pharmaceutical Physicians Association |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national